维普期刊资源整合服务平台（V6.5）

150篇 您的检索式：作者名="ISLA D"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Applications of genomics in NSCLC显示文摘	Rosell R Cobo M Isla D		0，，2：	2
2	Oral cloze: a backup exercise for interpreting 显示文摘	Anaya D~vila Garibi G & Lopez Islas J	1990	Meta: Journal des traducteurs / Meta: Translators''Journal1990，，3：	1
3	Safety of bevacizumab-based therapy as first-line treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): M019390 (SAIL)显示文摘	Dansin E Mezger J Isla D	2008	J Clin Oncol2008，26，：	1
4	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oneol2004，15，8：	1
5	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1
6	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non small cell lung cancer cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1
7	ERCC1 mRNA-based randomized phase Ⅲ trial of docetaxel(doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage Ⅳ non-small-cell lung cancer (NSCLC) patients(p)显示文摘	Rosell R Cobo M Isla D		0，，1：	1
8	Customizing cisplatin based on quantitative excision repair cross-complementing Ⅰ mRNA expres- sion:aphase Ⅲ trial in non-small-cell lung cancer显示文摘	Cobo M Isla D Massuti B	2007	J Clin On- col2007，25，19：	1
9	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin- treated advanced non-small cell lung cancer 显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1
10	ERCC1 mRNA-based randomized phase Ⅲ trial of docetaxel doublets with cisplatin or gemcitabine in stage Ⅳ non-small-cell lung cancer ( NSCLC ) patients显示文摘	Rosell R Cobo M Isla D	2005	Proc Am Soc Clin Oncol2005，24，：	1
11	ERCC1 mRNA-based ran- domized phase Ⅲ trial of docetaxel (doc) doublets with cisplatin (cis) or gemeitabine (gem) in stagelV non small-cell Lung canc-er (N SCLC) patients 显示文摘	Rosell R Cobo M Isla D	2005	J ClinOncol2005，23，1：	1
12	Hiarmacogenomics andgemcitabine 显示文摘	Rosell R Cobo M Isla D	2006	Arm Oncol2006，17，5：	1
13	High correspondence betweenEGFR mutations in tissue and in circulating DNA formnon-small-cell lung cancer (NSCLC) patients (p) with poor per-formance status (PS)显示文摘	Moran T Paz-Ares L Isla D	2007	J Clin Oncol2007，25，18：	1
14	Customizing cisplatin based on quantitative excision repair cross-complementing1 mRNA expression:a phase Ⅲ trial in non-small-cell lung cancer显示文摘	Cobo M Isla D Massuti B	2007	J Clin Oncol2007，25，19：	1
15	In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators显示文摘	de Isla NG Mainard D Muller S	2008	Biomed Mater Eng2008，18，1：	1
16	Pharmacogenomics and gemcitabine显示文摘	Rosell R Cobo M Isla D		0，，5：	1
17	ERCC1 mRNA-based randomized phase Ⅲ trial of docetaxel doublets with cisplatin or gemcitabine in stage Ⅳ non-smal cell lung cancer (NSCLC) patients显示文摘	ROSELL R COBO M ISLA D	2005	Proc Am Soc Clin Oncol2005，24，：	1
18	Pharmacogenomics and gemcitabine 显示文摘	Rosell R Cobo M Isla D	2006	Annals of Oncology2006，17，：	1
19	Customizing cisplatin based on quantitativeexcisionrepaircross-complementing 1 mRNA expression:a phase Ⅲ trial in non-small-cell lung cancer显示文摘	Cobo M Isla D Massuti B	2007	J Clin Onco12007，25，19：	1
20	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-smallcell lung cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示